Irlbeck M, Forst H, Briegel J, Haller M, Peter K
Institut für Anaesthesiologie, Ludwig-Maximilians-Universität München.
Anaesthesist. 1995 Jul;44(7):493-500. doi: 10.1007/s001010050182.
Pulse contour cardiac output (PCCO) is an easily applicable method for continuous measurement of cardiac output in critically ill patients. Calculation of stroke volume is possible by analysing the area under the systolic part of the arterial pulse pressure waveform together with an individual calibration factor (Zao) to account for the individually variable vascular impedance. Since vascular impedance is potentially affected by altered vascular tone, it was the aim of the present study to examine the validity of PCCO in ICU patients receiving various dosages of a variety of vasoactive drugs. PATIENTS AND METHODS. Continuous cardiac output was measured in 20 ICU patients for a total of 110 h using the pulse contour method. The precision of PCCO was determined in comparison with its calibration reference, the thermodilution method (TDCO): (1) during administration of vasoactive drugs at a constant rate and (2) during conditions with altered vascular tone and haemodynamics elicited by changes in vasoactive drug dosage. For this purpose, the patients received varying dosages of vasoactive drugs (dopamine, dobutamine, epinephrine, norepinephrine, nitroglycerin, prostacyclin and urapidil). RESULTS. A total of 165 data sets was obtained, each consisting of the average of four capnometrically triggered TDCO measurements and the corresponding PCCO values. The relative difference between methods (+/- 2 SD) was +/- 23.9% (SD 0.85 l.min-1; r = 0.93) if a single calibration at the beginning of measurement series was performed (Fig. 2). The bias of the mean cardiac output values of both methods was -0.09 l.min-1. The precision of PCCO improved to +/- 15.7% by additional calibrations (SD 0.56.min-1; r = 0.96; bias 0.003 l.min-1). Data of two patients showed that recalibration may be necessary after extreme haemodynamic changes due to septic shock or cooling. Alteration of vascular tone by clinically used dosage of vasoactive drugs, however, had no destabilizing effect on the pulse contour method. CONCLUSIONS. It could be demonstrated that PCCO provides a valuable method for continuous cardiac output measurement in the intensive care setting with a precision comparable to that of thermodilution.
脉搏轮廓心输出量(PCCO)是一种易于应用的方法,可用于危重症患者心输出量的连续测量。通过分析动脉脉压波形收缩期部分的面积,并结合个体校准因子(Zao)来计算每搏输出量,以考虑个体可变的血管阻抗。由于血管阻抗可能受到血管张力改变的影响,本研究的目的是检验PCCO在接受不同剂量各种血管活性药物的重症监护病房(ICU)患者中的有效性。患者和方法。使用脉搏轮廓法对20例ICU患者连续测量心输出量,共测量110小时。通过与校准参考方法热稀释法(TDCO)比较来确定PCCO的精度:(1)在以恒定速率给予血管活性药物期间;(2)在因血管活性药物剂量变化引起血管张力和血流动力学改变的情况下。为此,患者接受了不同剂量的血管活性药物(多巴胺、多巴酚丁胺、肾上腺素、去甲肾上腺素、硝酸甘油、前列环素和乌拉地尔)。结果。共获得165组数据集,每组数据集由四次通过二氧化碳波形图触发的TDCO测量值的平均值和相应的PCCO值组成。如果在测量系列开始时进行一次校准,两种方法之间的相对差异(±2标准差)为±23.9%(标准差0.85升/分钟;r = 0.93)(图2)。两种方法的平均心输出量值的偏差为-0.09升/分钟。通过额外校准,PCCO的精度提高到±15.7%(标准差0.56升/分钟;r = 0.96;偏差0.003升/分钟)。两名患者的数据表明,在因感染性休克或降温导致极端血流动力学变化后,可能需要重新校准。然而,临床使用剂量的血管活性药物引起的血管张力改变对脉搏轮廓法没有不稳定作用。结论。可以证明,PCCO为重症监护环境中心输出量的连续测量提供了一种有价值的方法,其精度与热稀释法相当。